The U.S. Food and Drug Administration (FDA) has granted regenerative medicine advanced therapy (RMAT) designation to FT819, a cell therapy Fate Therapeutics is developing to treat lupus. An RMAT ...

Lupus & You is a free educational series where people with lupus and their family and friends can learn more about the latest in lupus research and managing the disease. Speakers Dr. Daniel Clauw and ...

“Non-comedogenic means a product won’t clog your pores”, she explains. “It’s designed to sit on the skin without causing congestion, which helps prevent breakouts and blackhead ...

Remegen Co. Ltd. emerged as a surprise challenger in the generalized myasthenia gravis space, unveiling positive phase III data of its China-approved lupus drug, telitacicept (RCT-18; Tai’ai), in the ...

If your daily moisturizer is made with comedogenic ingredients, they’re more likely to clog your pores and lead to pesky breakouts. “Certain moisturizers, particularly those containing heavier oils ...

The Lupus Foundation of America (LFA) is excited to share that enrollment for the MiSLE (Mesenchymal Stromal Cells in Systemic Lupus Erythematosus) study was officially completed on February 21, 2025 ...

Mononeuritis multiplex affects 1%–9% of people with systemic lupus erythematosus and requires urgent interspecialty involvement and treatment with immunosuppressive medications. A detailed history and ...